[{"Assets_0_Q1_USD":"454341000.0","CIK":"1628171","CommonStockSharesIssued_0_Q1_shares":"59003644.0","CommonStockSharesOutstanding_0_Q1_shares":"59003644.0","Country":"United States","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-28018000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-21738000.0","NetIncomeLoss_1_Q1_USD":"-19519000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_1_Q1_USD":"-19519000.0","RevenuesConverted_1_Q1_USD":"11546000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q1_USD":"385316000.0","Ticker":"RVMD","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":"29297698.0","filed":"20200514","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"REVOLUTION MEDICINES, INC.","period":"20200331","qtrs":"0","uom":"USD"}]